Diabetes mellitus: Epidemiology, genetics and pathogenetic mechanisms;Epidemiología, genética y mecanismos patogénicos de la diabetes mellitus

Revista Espanola de Cardiologia Suplementos

Volumn 7, Issue H, 2007, Pages

  Calderón Montero, Alberto ^a,b  

^a Servicio de Medicina de Familia   (Spain)

^b Centro de Salud Rosa Luxemburgo   (Spain)

Author keywords

Epidemiology; Pa thophysiology; Type 2 diabetes mellitus

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; INSULIN;

ADIPOCYTE; ARTICLE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETOGENESIS; DIET; GENETICS; HUMAN; HYPERINSULINEMIA; IMMOBILIZATION; IMMUNITY; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PREVALENCE; PUBLIC HEALTH PROBLEM; RISK FACTOR; SITTING; SMOKING;

EID: 38149061028     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1131-3587(07)75268-8     Document Type: Article

References (44)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemia. Nature. 2001;414:782-7.
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease. A Statement for healthcare proffesionals from the American Heart Association. Circulation. 1999;100:1134-46.
3. Goday A. Epidemiología de la diabetes mellitus y sus complicaciones no coronarias. Rev Esp Cardiol. 2002;55:657-70.
4. Green A, Gale EAM, Patterson C. The EURODIAB Subarea A Study Group. Wide variation in the incidente of chilhood onset insulin-dependent diabetes mellitus in Europe: The Eurodiab ACE Study. Lancet. 1992;339:905-9.
5. Karvonen M, Pitkaniemi J, Tuomilehto J, for the Finish Chilhood Diabetes Registry Group. The onset age of type 1 diabetes in Finnish children has become younger. Diabetes Care. 1999;22: 1066-70.
6. Rewers M, La Porte RE, King H, Tuomiletho J. Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in chilhood. World Health Stat Q. 1988;41:179-89.
7. The DECODE Study Group. Age and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61-9.
8. The DECODA Study Group. Age and sex-specific prevalences of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care. 2003;26:1770-80.
9. Franch Nadal J, Álvarez Torrices JC, Álvarez Guisasola F, Diego Domínguez F, Hernandez Mejía R, Cueto Espinar A. Epidemiología de la diabetes mellitus en la provincia de León. Med Clin (Barc). 1992;98:607-11.
10. Bayo J, Sola C, García F, Latorre PM, Vázquez JA. Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya). Med Clin (Barc). 1993;101:609-12.
11. Castell C, Tresserras R, Serra J, Godoy A, LLoveras G, Salleras Ll. Prevalence of diabetes in Catalonia (Spain): an oral glucosa tolerante test-based population study. Diab Res Clin Practice. 1999;43:33-40.
12. De Pablos Velasco PL, Martínez Martínez FJ, Rodríguez-Perez F, Anía BJ, Losada A, Betancor P. Prevalence and determinants of diabetes mellitus and glucose intolerance in Canarian Caucasian population: comparison of the ADA and the 1985 WHO criteria. The Guia Study. Diabetes Med. 2001;18:235-41.
13. Botas P, Delgado E, Castaño G, Díaz de Greñu C, Prieto J, Diaz-Cadórniga FJ. Prevalencia de diabetes mellitus e intolerancia a la glucosa en población entre 30 y 75 años en Asturias. Rev Clin Esp. 2002;202:423-9.
14. Karvonen M, Viik-Kejander M, Moltchanova E, Libman I, LaPorte R, Tuomilheto J, for the Diabetes Mondiale (DiaMond) Project Group. Incidence of chilhood type 1 diabetes worldwide. Diabetes Care. 2000;23:1516-26.
15. Gujral JS, McNally PG, Botha JL, Burden AC. Chilhood onset diabetes in the white and South Asian population in Leicestershire, UK. Diabet Med. 1994;11:570-2.
16. De Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouver CDA, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a dutch population. The Hoorn Study. JAMA. 2001;16:2109-13.
17. Cabezas-Cerrato J, for the Neuropathy Spanish Study Group of the Spanish Diabetes Society. The prevalence of clinical diabetic polineurophaty in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998;41:1263-9.
18. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treaning diabetic retinopathy. Ann Intern Med. 1996;124:164-9.
19. Amenabar J, García López F, Robles NR, Sancho R. Informe anual del registro de pacientes en diálisis y trasplante renal en España. Nefrología. 2000;20:34.
20. Goday A. Epidemiología de la diabetes mellitus. En: Soria B, coordinador. Abordaje integral de la diabetes. Barcelona: Editorial Bernat Soria; 2006. p. 19-30.
21. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol. 1997;146:214-22.
22. Hayashy T, Boyko EJ, Leonetti DL, McNelly MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care. 2003;26:650-5.
23. Toumiletho J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Illane-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
24. Knowler WC, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
25. Wolever TM, Hamad S, Gittelsohn J, Gao J, Hanley AJ, Harris SB, et al. Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal comunity. Am J Clin Nutr. 1997;66:1470-4.
26. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflamation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001;50:2384-9.
27. Patja K, Jousilathi P, Hu G, Valle T, Qiao Q, Toumiletho J. Effect of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-age Finnish men and women. J Intern Med. 2005;258:356-62.
28. Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB, et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dyzigotic twin and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999;318:698-702.
29. Singal DP, Blajmann MA. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 1973;22:429-32.
30. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984;33:176-83.
31. Kupila A, Muona P, Simmel T, Arvilommi P, Savolainen H, Hamalainen AM, et al. Feasibility and immunological prediction of type 1 diabetes in a population-based cohort. Diabetologia. 2001;44:290-7.
32. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn C. Obesity associated with a mutation in a genetic regulator of adipocite diferentiation. N Engl J Med. 1998;339:953-9.
33. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a metaanalysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia. 1998;41:1511-5.
34. Schatz D, Krisher J, Horne G, Riley W, Spillar R, Silverstein J, et al. Islet cell antibodies predict insulin-dependent diabetes in United States shool age children as powerfully as in unaffected relatives. J Clin Invest. 1994;93:2403-7.
35. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increase beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-10.
36. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia. 1978;15:417-21.
37. The UKPDS Group. Intensive blood-glucos control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
38. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. Distincts effects of saturated and monounsatturated fatty acids on beta cell turnover and function. Diabetes. 2001;50:69-76.
39. Yki-Jarvinen H. Insulin resistance in type 2 diabetes. En: Pickup JC, Williams G, editors. Textbook of diabetes. Oxford: Blackwell; 2003. p. 22-1.
40. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, et al. PPAR gamma is required for placental, cardiac and adipose tissue development. Moll Vell. 1999;4:585-95.
41. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, et al. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 1995;269:1108-12.
42. Smith U. Impaired («diabetic») insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue? Int J Obes Relat Metab Disord. 2002;26:897-904.
43. Friedman JM . Leptin, leptin receptors and the control of body weight. Nature. 1998;395:763-70.
44. Arita Y, Hihara S, Ouchi N, Takahasi M, Maeda K, Miyagawa, J et al. Paradoxal decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.